Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.520
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $39.42 million as of November 21, 2024. Its market cap has decreased by -42.62% in one year.
Market Cap
39.42M
Enterprise Value
38.01M
1-Year Change
-42.62%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $39.42M, a decrease of -75.80%. That is a compound annual growth rate of -33.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 39.42M | -36.45% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LAVA Therapeutics | 40.76M |
| BioLineRx | 40.40M |
| Verrica Pharmaceuticals | 40.10M |
| Nexalin Technology | 40.03M |
| iCAD, Inc. | 39.66M |
| DIH Holding US | 38.92M |
| Lexaria Bioscience | 38.40M |
| AN2 Therapeutics | 37.90M |